231 related articles for article (PubMed ID: 35581348)
1. Post-acute COVID-19 outcomes in children requiring hospitalisation.
Bossley CJ; Kavaliunaite E; Harman K; Cook J; Ruiz G; Gupta A
Sci Rep; 2022 May; 12(1):8208. PubMed ID: 35581348
[TBL] [Abstract][Full Text] [Related]
2. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.
Borch L; Holm M; Knudsen M; Ellermann-Eriksen S; Hagstroem S
Eur J Pediatr; 2022 Apr; 181(4):1597-1607. PubMed ID: 35000003
[TBL] [Abstract][Full Text] [Related]
3. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
[TBL] [Abstract][Full Text] [Related]
4. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.
Fernández-de-Las-Peñas C; Gómez-Mayordomo V; Cuadrado ML; Palacios-Ceña D; Florencio LL; Guerrero AL; García-Azorín D; Hernández-Barrera V; Arendt-Nielsen L
Cephalalgia; 2021 Nov; 41(13):1332-1341. PubMed ID: 34134526
[TBL] [Abstract][Full Text] [Related]
5. Persistent symptoms after COVID-19 in children and adolescents from Argentina.
Seery V; Raiden S; Penedo JMG; Borda M; Herrera L; Uranga M; Marcó Del Pont M; Chirino C; Erramuspe C; Alvarez LS; Lenoir M; Morales LD; Davenport C; Huespe Auchter S; Monsalvo L; Sastoque L; Gavazzi M; Russo C; Sananez I; Pando MLÁ; Laufer N; Muiños R; Ferrero F; Geffner J; Arruvito L
Int J Infect Dis; 2023 Apr; 129():49-56. PubMed ID: 36736574
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
[TBL] [Abstract][Full Text] [Related]
7. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.
Dennis A; Wamil M; Alberts J; Oben J; Cuthbertson DJ; Wootton D; Crooks M; Gabbay M; Brady M; Hishmeh L; Attree E; Heightman M; Banerjee R; Banerjee A;
BMJ Open; 2021 Mar; 11(3):e048391. PubMed ID: 33785495
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Health Symptoms and Sequelae Following SARS-CoV-2 Infection: An Evidence Map.
Franco JVA; Garegnani LI; Oltra GV; Metzendorf MI; Trivisonno LF; Sgarbossa N; Ducks D; Heldt K; Mumm R; Barnes B; Scheidt-Nave C
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011562
[TBL] [Abstract][Full Text] [Related]
9. Course of fatigue among patients previously hospitalised due to COVID-19.
Mazurkiewicz I; Chatys-Bogacka Ż; Słowik J; Zdanecka M; Siwiec-Koźlik A; Słowik A; Drabik L; Wnuk M
Neurol Neurochir Pol; 2023; 57(1):101-110. PubMed ID: 36810758
[TBL] [Abstract][Full Text] [Related]
10. Is SARS-CoV-2 the only cause of long-COVID?
Pintos-Pascual I; Moreno-Torres V; Ibánez-Estéllez F; Corrales-Rodriguez P; Treviño A; Corpas M; Corral O; Soriano V; de Mendoza C
AIDS Rev; 2022 Dec; 24(4):183-196. PubMed ID: 36427058
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Long-Term Effects of Symptomatic and Asymptomatic SARS-CoV-2 Infection in Children and the Changing Pathogenesis of Common Childhood Viruses Driven by the COVID-19 Pandemic.
Parums DV
Med Sci Monit; 2022 Aug; 28():e937927. PubMed ID: 35909366
[TBL] [Abstract][Full Text] [Related]
12. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study.
Søraas A; Kalleberg KT; Dahl JA; Søraas CL; Myklebust TÅ; Axelsen E; Lind A; Bævre-Jensen R; Jørgensen SB; Istre MS; Kjetland EF; Ursin G
PLoS One; 2021; 16(8):e0256142. PubMed ID: 34437579
[TBL] [Abstract][Full Text] [Related]
13. Long COVID in children and adolescents.
Stephenson T; Shafran R; Ladhani SN
Curr Opin Infect Dis; 2022 Oct; 35(5):461-467. PubMed ID: 36098262
[TBL] [Abstract][Full Text] [Related]
14. Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection.
Brito-Zerón P; Acar-Denizli N; Romão VC; Armagan B; Seror R; Carubbi F; Melchor S; Priori R; Valim V; Retamozo S; Pasoto SG; Trevisani VFM; Hofauer B; Szántó A; Inanc N; Hernández-Molina G; Sebastian A; Bartoloni E; Devauchelle-Pensec V; Akasbi M; Giardina F; Bandeira M; Sisó-Almirall A; Ramos-Casals M;
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):57-65. PubMed ID: 34874821
[TBL] [Abstract][Full Text] [Related]
15. Italian intersociety consensus on management of long covid in children.
Esposito S; Principi N; Azzari C; Cardinale F; Di Mauro G; Galli L; Gattinara GC; Fainardi V; Guarino A; Lancella L; Licari A; Mancino E; Marseglia GL; Leonardi S; Nenna R; Zampogna S; Zona S; Staiano A; Midulla F
Ital J Pediatr; 2022 Mar; 48(1):42. PubMed ID: 35264214
[TBL] [Abstract][Full Text] [Related]
16. Long COVID-19 in children: an Italian cohort study.
Trapani G; Verlato G; Bertino E; Maiocco G; Vesentini R; Spadavecchia A; Dessì A; Fanos V
Ital J Pediatr; 2022 Jun; 48(1):83. PubMed ID: 35659358
[TBL] [Abstract][Full Text] [Related]
17. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
18. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort.
Caspersen IH; Magnus P; Trogstad L
Eur J Epidemiol; 2022 May; 37(5):539-548. PubMed ID: 35211871
[TBL] [Abstract][Full Text] [Related]
19. [Frequency, spectrum and risk factors of long COVID].
Pink I; Welte T
Inn Med (Heidelb); 2022 Aug; 63(8):813-818. PubMed ID: 35925071
[TBL] [Abstract][Full Text] [Related]
20. [Monitoring the development of post-COVID–19 syndrome].
Tamasi J; Kalabay L
Orv Hetil; 2022 Feb; 163(9):335-342. PubMed ID: 35220274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
